BU biomedical engineers say a new breakthrough could open doors to continuous health-monitoring devices and wearables.
Gluten is enemy No. 1 for those with celiac disease, and it's hard to avoid. Episodes of this chronic autoimmune illness can be triggered by ingesting gluten, a key protein in wheat and some other grains. Researchers have been exploring how gut bacteria, especially Bifidobacteria, could be used as a treatment. Now, scientists publishing the results of laboratory experiments in ACS' Journal of Agricultural and Food Chemistry report how specific types of Bifidobacteria work.
Crohn's disease is a chronic inflammatory disorder of the intestine that, in most cases, relapses episodically. As of now, there is no cure for this disease. A research group led by the Technical University of Munich (TUM) has discovered a marker at a microscopic level, which can be used to identify patients that show a high probability of suffering from an inflammation recurrence in the immediate future. With this insight, therapeutic counter-measures may be employed at an earlier stage.
A plant-based diet is a good choice for both climate and health. However, many plant-based products, especially legumes, contain FODMAP compounds that are poorly digestible and cause unpleasant intestinal symptoms. A study by VTT and Finnish companies succeeded in breaking down FODMAPs with enzymes and producing new, stomach-friendly plant-based food products.
Are overweight women less fertile? Does primary ovarian insufficiency increase risks for obesity and diabetes? For years the controversy regarding the connection between reproductive health and body mass index has continued. A new study assessed the effect of ovarian reserve on obesity and glucose metabolism and found no correlation. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS).
Individuals with diabetes are at increased risk for bacterial, parasitic and viral infections. New research published in Endocrine Reviews, a journal of the Endocrine Society, illuminates how intersections of the coronavirus infection (COVID-19) and type 2 diabetes may require new approaches in treatment for hospitalized patients.
A team of researchers in Korea believes to have discovered a synthetic gold-based compound which may help patients with obesity. The nanoparticles were tested in both 3T3-L1 and HepG2 cell lines, which are two known candidates for studying obesity and related disease models.
A new Finnish study demonstrated the benefits of large-scale genomic information in estimating the risk of onset for cardiac diseases, diabetes and common cancers. The findings, based on the FinnGen research dataset encompassing more than 135,000 Finns, show that new tools based on genomic data are helpful in identifying high-risk individuals not identified by the current system.
This observational study pooled data from five study groups to examine whether cumulative blood pressure levels might explain racial differences in risk for cognitive decline later in life.
Risks for obesity and type 2 diabetes in adulthood were compared among 33,000 women born by cesarean or vaginal delivery between 1946 and 1964 in this observation study that included participants in the Nurses' Health Study II.